July 4 (SeeNews) - Swiss pharmaceutical group Novartis has completed the transfer of assets worth 691.6 million euro ($753.7 million) of Slovenian subsidiary Lek to its other local unit, Novartis Slovenia, Ljubljana-based media reported.